APhA Policy Manual

Compounding with Multicomponent Vehicles

PHARMACY PRACTICE

APhA encourages companies that offer multi-component vehicles for compounding to list all ingredients and to restrict claims about the vehicles to the structure and function of the ingredients in those vehicles unless clinical evidence exists to support more specific claims.
When claims are made by companies for systemic delivery of active ingredients in multicomponent vehicles, APhA encourages pharmacists to secure bioavailability data in support of such claims.